Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms

Joseph Tripodi1, Ronald Hoffman1, Vesna Najfeld2, Rona Weinberg31The Myeloproliferative Disorders Program, Tisch Cancer Institute, Department of Medicine and 2Department of Medicine and Pathology, Mount Sinai School of Medicine, 3The Myeloproliferative Disorders Program, Cellular Therapy Laboratory,...

Full description

Bibliographic Details
Main Authors: Joseph Tripodi, Ronald Hoffman, Vesna Najfeld, et al
Format: Article
Language:English
Published: Dove Medical Press 2010-09-01
Series:Cancer Management and Research
Online Access:http://www.dovepress.com/frequency-of-heterozygous-tet2-deletions-in-myeloproliferative-neoplas-a5301